会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • 멜라노코틴 수용체의 항진제
    • MELANOCORTIN 4 RECEPTOR(MC4R)AGONIST
    • KR1020030035592A
    • 2003-05-09
    • KR1020010067706
    • 2001-10-31
    • 주식회사 엘지생명과학
    • 이구박희술정원혁안인애유현주임현주박숙경최덕영
    • C07D417/14
    • PURPOSE: Provided is a melanocortin 4 receptor(MC4R) agonist, to accelerate the function of the melanocortin 4 receiptor(MC4R) and to prevent and treat diseases associated with the MC4R such as obesity, diabetes and sexual disorder. CONSTITUTION: Compounds functioning as a melanocortin 4 receptor(MC4R) agonist are represented by formula(1), wherein A is hydrogen, COR1, CO2R1, SO2R1, SO2NHR1, SO2N(R1)2, PO(OR1)2, C1-8-alkyl, (CH2)n, (CH2)n-aryl or (CH2)n-heteroaryl in which R1 is hydrogen, C1-8-alkyl, (CH2)n-C3-7-cycloalkyl, (CH2)n-aryl or (CH2)n-heteroaryl, n is an integer of 1 to 7; B and E are independently hydrogen, C1-8-alkyl, (CH2)n-C3-7-cycloalkyl, (CH2)n-aryl, (CH2)n-heteroaryl, (CH2)n-heterocycle, (CH2)n-amino, (CH2)n-(alkyl)amino, (CH2)n-(dialkyl)amino, (CH2)n-amide(CONH2) or (CH2)n-O(CH2)aryl in which n is an integer of 0 to 7; C is (CH2)m-heteroaryl, (CH2)m-heterocycle, (CH2)m-NH-heteroaryl, (CH2)m-NH-heterocycle, (CH2)m-NH-(alkylsulfonyl), (CH2)m-NH-(arylsulfonyl), (CH2)m-NH-alkoxycarbonyl, (CH2)m-NH-alkylamino carbamoyl, (CH2)m-NH-C(O)-heteroaryl, (CH2)m-NH-C(O)-heterocycle, (CH2)m-NH-(CH2)m-heteroaryl, (CH2)m-NH-(CH2)m-heterocycle, (CH2)m-NH-C(O)-(CH2)m-heteroaryl, (CH2)m-NH-C(O)-(CH2)m-heterocycle, C(O)-heterocycle, (CH2)m-NH-alkylester, (CH2)m-NH-alkyl amide, alkoxycarbonyl, (CH2)m-O-(alkylsulfonyl), (CH2)m-O-(arylsulfonyl), alkylamino carbamoyl, hydroxyalkyl amino carbamoyl, arylamino carbamoyl or hydrogen which are substituted or unsubstituted by a substituent selected from the group consisting of halogen, C1-5 alkyl, trifluoromethyl, hydroxy, C1-3 alkyloxy, amino, (C1-3 alkyl)amino, (C1-3 alkyl)2amino, cyano, carboxy(CO2H), CO2-C1-3 alkyl, CONH2, amidine(C(NH)NH2), nitro and oxo(C=O) in which m is an integer of 0 to 2; D is piperidine, pyrrolidine, hexamethyleneimine, 2 or 3 oxo piperidine and hexamethyleneimine, pyrrolidine or dialkylamine; and Cy is C5-C7-aryl or C5-7 cycloalkyl which is substituted or unsubstituted by a substituent selected from the group consisting of C1-C5-alkyl, halogen, trifluoromethyl, hydroxy, C1-C3-alkyloxy, amino, (C1-C3-alkyl)amino, di(C1-C3-alkyl)amino and oxo(C=O).
    • 目的:提供黑皮质素4受体(MC4R)激动剂,以加速黑皮质素4受体(MC4R)的功能,并预防和治疗与MC4R相关的疾病,如肥胖症,糖尿病和性障碍。 构成:作为黑皮质素4受体(MC4R)激动剂起作用的化合物由式(1)表示,其中A为氢,COR1,CO2R1,SO2R1,SO2NHR1,SO2N(R1)2,PO(OR1)2, 烷基,(CH 2)n - ,(CH 2)n - 芳基或(CH 2)n - 杂芳基,其中R 1是氢,C 1-8 - 烷基,(CH 2)n -C 3 -7-环烷基,(CH 2) (CH 2)n - 杂芳基,n为1〜7的整数。 B和E独立地是氢,C 1-8烷基,(CH 2)n -C 3 -7-环烷基,(CH 2)n - 芳基,(CH 2)n - 杂芳基,(CH 2)n - 杂环,(CH 2) 氨基,(CH2)n-(烷基)氨基,(CH2)n-(二烷基)氨基,(CH2)n-酰胺(CONH2)或(CH2)nO(CH2)芳基,其中n为0至7的整数 ; C(CH 2)m - 杂芳基,(CH 2)m - 杂环,(CH 2)m -NH-杂芳基,(CH 2)m -NH-杂环,(CH 2)m -NH-(烷基磺酰基) (CH2)m-NH-烷氧基羰基,(CH2)m-NH-烷基氨基氨基甲酰基,(CH2)m-NH-C(O) - 杂芳基,(CH2)m-NH-C(O) - 杂环,(CH 2)m -NH-(CH 2)m - 杂芳基,(CH 2)m -NH-(CH 2)m - 杂环,(CH 2)m -NH-C(O) - (CH 2) (CH 2)m -NH-C(O) - (CH 2)m - 杂环,C(O) - 杂环,(CH 2)m -NH-烷基酯,(CH 2)m -NH-烷基酰胺,烷氧基羰基,(CH 2) mO-(烷基磺酰基),(CH 2)m O-(芳基磺酰基),烷基氨基氨基甲酰基,羟烷基氨基氨基甲酰基,芳基氨基氨基甲酰基或氢,其被选自卤素,C 1-5烷基,三氟甲基,羟基 ,C 1-3烷氧基,氨基,(C 1-3烷基)氨基,(C 1-3烷基)2氨基,氰基,羧基(CO 2 H),CO 2 -C 1-3烷基,CONH 2,脒(C(NH)NH 2) 和氧代(C = O),其中m为0-2的整数; D是哌啶,吡咯烷,六亚甲基亚胺,2或3个氧代哌啶和六亚甲基亚胺,吡咯烷或二烷基胺; 并且Cy是被选自C 1 -C 5 - 烷基,卤素,三氟甲基,羟基,C 1 -C 3 - 烷氧基,氨基,(C 1 -C 3 - 烷氧基) C3-烷基)氨基,二(C1-C3-烷基)氨基和氧代(C = O)。
    • 5. 发明公开
    • 멜라노코틴 수용체의 항진제
    • 梅兰康汀受体激动剂
    • KR1020030035586A
    • 2003-05-09
    • KR1020010067699
    • 2001-10-31
    • 주식회사 엘지생명과학
    • 이구박희술정원혁안인애유현주임현주박숙경권오환심동섭
    • C07D403/12
    • PURPOSE: Provided is a composition of melanocortin receptor(MRC) agonists, containing, as an active ingredient, a compound of formula(1), its pharmaceutically acceptable salt, a hydrate, a solvate and an isomer. CONSTITUTION: The composition of melanocortin receptor(MRC) agonists comprises a compound of the formula(1) having excellent antagonistic action on melanocortin receptor. In the formula(1), Y is as defined in the specification; X is H2, O or S; B is hydrogen, substituted or unsubstituted C1-C8 alkyl, (CH2)n-C3-C8 cyclo alkyl, (CH2)n-C3-C10 aryl, (CH2)n-C3-C10-hetero aryl, (CH2)n-C3-C10-hetero cyclo alkyl or (CH2)n-O(CH2)-C3-C10-aryl, wherein n is an integer of from 1 to 7; C is substituted or unsubstituted C1-C8 alkyl, (CH2)m-C3-C8 cyclo alkyl, (CH2)m-C3-C10 aryl, (CH2)m-C3-C10-hetero aryl, (CH2)m-C3-C10-hetero cyclo alkyl, wherein m is an integer of from 0 to 2; and D is (CH2)m-R2, wherein m is an integer of from 0 to 3.
    • 目的:提供含有作为活性成分的式(1)化合物,其药学上可接受的盐,水合物,溶剂合物和异构体的黑皮质素受体(MRC)激动剂的组合物。 构成:黑皮质素受体(MRC)激动剂的组成包含对黑皮质素受体具有优异拮抗作用的式(1)化合物。 在式(1)中,Y如说明书中所定义; X为H 2,O或S; B是氢,取代或未取代的C 1 -C 8烷基,(CH 2)n -C 3 -C 8环烷基,(CH 2)n -C 3 -C 10芳基,(CH 2)n -C 3 -C 10杂芳基,(CH 2) C 3 -C 10杂环烷基或(CH 2)n O(CH 2)-C 3 -C 10 - 芳基,其中n为1至7的整数; C是取代或未取代的C 1 -C 8烷基,(CH 2)m -C 3 -C 8环烷基,(CH 2)m -C 3 -C 10芳基,(CH 2)m -C 3 -C 10杂芳基,(CH 2)m -C 3- C 10 - 杂环烷基,其中m为0〜2的整数; D为(CH 2)m -R 2,m为0〜3的整数。
    • 6. 发明公开
    • 멜라노코틴 수용체의 항진제
    • 梅兰康汀受体激动剂
    • KR1020030027439A
    • 2003-04-07
    • KR1020010060726
    • 2001-09-28
    • 주식회사 엘지생명과학
    • 이구박희술정원혁안인애유현주최덕영권오환심동섭임현주박숙경
    • C07D417/14
    • PURPOSE: Provided are a compound of the formula(1) having excellent antibiotic activity, and a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof. Also, provided is a composition of melanocortin receptor agonists which contains them as active ingredients. CONSTITUTION: The compound represented by the formula(1) as defined in the specification is manufactured by the steps of: reaction of B-amino acid compound of the formula(2) with a compound of the formula(3) and followed by hydrolysis to give dipeptide compound of the formula(4); amide-coupling reaction of the compound of the formula(4) and a piperidine derivative of the formula(5), then followed by deprotection to give a compound of the formula(6); and coupling reaction of the compound of the formula(6) to introduce A group thereinto.
    • 目的:提供具有优异抗生素活性的式(1)化合物及其药学上可接受的盐,水合物,溶剂合物或异构体。 此外,提供含有它们作为活性成分的黑皮质素受体激动剂的组合物。 构成:本说明书中定义的由式(1)表示的化合物通过以下步骤制备:将式(2)的B-氨基酸化合物与式(3)的化合物反应,然后水解至 得到式(4)的二肽化合物; 式(4)化合物与式(5)的哌啶衍生物的酰胺偶联反应,然后脱保护,得到式(6)化合物; 和式(6)化合物的偶联反应以引入A基团。
    • 7. 发明公开
    • 멜라노코틴 수용체의 항진제
    • MELANOCORTIN 4 RECEIPTOR(MC4R)AGONIST
    • KR1020030035588A
    • 2003-05-09
    • KR1020010067701
    • 2001-10-31
    • 주식회사 엘지생명과학
    • 이구박희술정원혁안인애유현주최덕영권오환
    • C07D403/14
    • PURPOSE: A melanocortin 4 receptor(MC4R) agonist is provided, thereby accelerating the function of the melanocortin 4 receiptor(MC4R), and consequently preventing and treating diseases associated with the MC4R such as obesity, penile erection disorder, diabetes and inflammation. CONSTITUTION: Compounds functioning as a melanocortin 4 receptor(MC4R) agonist are represented by formula(1), wherein A is hydrogen, COR1, CO2R1, SO2R1, SO2NHR1, SO2N(R1)2, PO(OR1)2, C1-C8-alkyl, (CH2)n-C5-C10-aryl or (CH2)n-C5-C10-heteroaryl in which R1 is hydrogen, C1-C8-alkyl, (CH2)n-C3-C7-cycloalkyl, (CH2)n-C5-C10-aryl or (CH2)n-C5-C10-heteroaryl, n is an integer of 0 to 7; B and C are independently hydrogen, C1-C8-alkyl, (CH2)n-C3-C7-cycloalkyl, (CH2)n-C5-C10-aryl, (CH2)n-C5-C10-heteroaryl, (CH2)n-C5-C10-heterocycle or (CH2)n-O(CH2)-C5-C10-aryl in which n is an integer of 1 to 7; D is hydrogen, C1-C8-alkyl, (CH2)n-C3-C7-cycloalkyl, (CH2)n-C5-C10-aryl, (CH2)n-C5-C10-heteroaryl, (CH2)n-C5-C10-heterocycle or (CH2)n-O(CH2)-C5-C10-aryl in which n is an integer of 1 to 7; E is C5-C10-alkyl or (CH2)m-C5-C7-cycloalkyl in which m is an integer of 0 to 2; and F is (CH2)m-C5-C10-heteroaryl or (CH2)m-C5-C10-heterocycle in which n is an integer of 0 to 2.
    • 目的:提供黑皮质素4受体(MC4R)激动剂,从而加速黑皮质素4受体(MC4R)的功能,从而预防和治疗与MC4R相关的疾病,如肥胖,阴茎勃起障碍,糖尿病和炎症。 构成:作为黑皮质素4受体(MC4R)激动剂起作用的化合物由式(1)表示,其中A为氢,COR1,CO2R1,SO2R1,SO2NHR1,SO2N(R1)2,PO(OR1)2,C1-C8- 烷基,(CH2)n-C5-C10-芳基或(CH2)n-C5-C10-杂芳基,其中R1是氢,C1-C8-烷基,(CH2)n-C3-C7-环烷基,(CH2)n -C 5 -C 10 - 芳基或(CH 2)n -C 5 -C 10 - 杂芳基,n为0〜7的整数。 B和C独立地是氢,C1-C8-烷基,(CH2)n-C3-C7-环烷基,(CH2)n-C5-C10-芳基,(CH2)n-C5-C10-杂芳基,(CH2)n -C 5 -C 10 - 杂环或(CH 2)n O(CH 2)-C 5 -C 10 - 芳基,其中n为1至7的整数; D是氢,C 1 -C 8 - 烷基,(CH 2)n -C 3 -C 7 - 环烷基,(CH 2)n -C 5 -C 10 - 芳基,(CH 2)n -C 5 -C 10杂芳基,(CH 2)n -C 5 - C10-杂环或(CH2)nO(CH2)-C5-C10-芳基,其中n为1至7的整数; E为C 5 -C 10 - 烷基或(CH 2)m -C 5 -C 7 - 环烷基,其中m为0〜2的整数; 并且F是(CH 2)m -C 5 -C 10 - 杂芳基或(CH 2)m -C 5 -C 10 - 杂环,其中n是0至2的整数。
    • 8. 发明公开
    • 멜라노코틴 수용체의 항진제
    • MELANOCORTIN 4 RECEPTOR(MC4R)AGONIST
    • KR1020030035589A
    • 2003-05-09
    • KR1020010067702
    • 2001-10-31
    • 주식회사 엘지생명과학
    • 이구박희술정원혁안인애유현주최덕영심동섭
    • C07D417/14
    • PURPOSE: Provided are a melanocortin 4 receptor(MC4R) agonist and a composition for containing the same, to accelerate the function of the melanocortin 4 receiptor(MC4R), so as to prevent and treat diseases associated with the MC4R such as obesity, penile erection disorder, diabetes and inflammation. CONSTITUTION: Compounds functioning as a melanocortin 4 receptor(MC4R) agonist are represented by formula(1), wherein A is hydrogen, COR1, CO2R1, SO2R1, SO2NHR1, SO2N(R1)2, PO(OR1)2, C1-C8-alkyl, (CH2)n-C5-C7-aryl, or (CH2)n-C5-C7-heteroaryl in which R1 is hydrogen, C1-C8-alkyl, (CH2)n-C3-C7-cycloalkyl, (CH2)n-C5-C7-aryl or (CH2)n-C5-C7-heteroaryl and n is an integer of 1 to 7; B and E are independently hydrogen, C1-C8-alkyl, (CH2)n-C3-C7-cycloalkyl, (CH2)n-C5-C7-aryl, (CH2)n-C5-C7-heteroaryl, (CH2)n-C5-C7-heterocycle or (CH2)n-O(CH2)-C5-C7-aryl in which n is an integer of 1 to 7; Cy is C5-C7-aryl or C5-C7-cycloalkyl which is substituted or unsubstituted by a substituent selected from the group consisting of C1-C5-alkyl, halogen, trifluoromethyl, hydroxy, C1-C3-alkyloxy, amino, (C1-C3-alkyl)amino, di(C1-C3-alkyl)amino, oxo(C=O) and nitro; C is hydrogen, COR1, CO2R1, SO2R1, SO2NHR1, (CH2)m-C1-C8-alkylsulfonyl, (CH2)m-C1-C8-alkoxycarbonyl, amide(CONH2), (CH2)m-C1-C8-alkylcarbamoyl, C(O)-C5-C7-heteroaryl, (CO)-C5-C7-heterocycle, C(O)-(CH2)m-C5-C7-heteroaryl, C(O)-(CH2)m-C5-C7-heterocycle, (CH2)m-C5-C7-heteroaryl or (CH2)m-C5-C7-heterocycle in which R1 is C1-C8-alkyl or C5-C7-aryl and m is an integer of 0 to 2; and D is C5-C10-alkyl, (CH2)m-C5-C7-cycloalkyl, (CH2)m-C5-C7-aryl, (CH2)m-C5-C7-heterocycloalkyl I which m is an integer of 0 to 2.
    • 目的:提供黑皮质素4受体(MC4R)激动剂和含有它的组合物,以加速黑皮质素4受体(MC4R)的功能,以预防和治疗与MC4R相关的疾病,如肥胖,阴茎勃起 疾病,糖尿病和炎症。 构成:作为黑皮质素4受体(MC4R)激动剂起作用的化合物由式(1)表示,其中A为氢,COR1,CO2R1,SO2R1,SO2NHR1,SO2N(R1)2,PO(OR1)2,C1-C8- 烷基,(CH2)n-C5-C7-芳基或(CH2)n-C5-C7-杂芳基,其中R1是氢,C1-C8-烷基,(CH2)n-C3-C7-环烷基,(CH2) n-C 5 -C 7 - 芳基或(CH 2)n -C 5 -C 7 - 杂芳基,n为1至7的整数; B和E独立地是氢,C 1 -C 8 - 烷基,(CH 2)n -C 3 -C 7 - 环烷基,(CH 2)n -C 5 -C 7 - 芳基,(CH 2)n -C 5 -C 7 - 杂芳基,(CH 2)n C 5 -C 7 - 杂环或(CH 2)n O(CH 2)-C 5 -C 7 - 芳基,其中n为1至7的整数; Cy是C 1 -C 5 - 烷基,卤素,三氟甲基,羟基,C 1 -C 3 - 烷氧基,氨基,(C 1 -C 6 - C3-烷基)氨基,二(C1-C3-烷基)氨基,氧代(C = O)和硝基; (CH2)m-C1-C8-烷基磺酰基,(CH2)m-C1-C8-烷氧基羰基,酰胺(CONH2),(CH2)m-C1-C8-烷基氨基甲酰基, C(O)-C 5 -C 7 - 杂芳基,(CO)-C 5 -C 7 - 杂环,C(O) - (CH 2)m -C 5 -C 7 - 杂芳基,C(O) - (CH 2)m -C 5 -C - 杂环,(CH 2)m -C 5 -C 7 - 杂芳基或(CH 2)m -C 5 -C 7 - 杂环,其中R 1是C 1 -C 8 - 烷基或C 5 -C 7 - 芳基,m是0-2的整数; D为C 5 -C 10 - 烷基,(CH 2)m -C 5 -C 7 - 环烷基,(CH 2)m -C 5 -C 7 - 芳基,(CH 2)m -C 5 -C 7 - 杂环烷基,m为0〜 2。